Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

Market Cap	3.90B +38.3%
Revenue (ttm)	532.26M +12.9%
Net Income	135.88M +10.9%
EPS	0.89 +8.5%
Shares Out	150.34M
PE Ratio	29.12
Forward PE	n/a
Dividend	0.12 (0.44%)
Ex-Dividend Date	May 20, 2025

Volume	5,918,385
Average Volume	6,167,281
Open	26.66
Previous Close	26.42
Day's Range	25.01 - 26.88
52-Week Range	17.68 - 27.95
Beta	0.38
RSI	59.66
Earnings Date	Aug 14, 2026

About SHE:001367

Zhejiang Haisen Pharmaceutical Co., Ltd. engages in the research and development, production, sale, and import and export of pharmaceutical intermediates, active pharmaceutical ingredients, and preparations in China and internationally. The company offers active pharmaceutical ingredients for anti-gastric ulcer, antilipemic agent, antipyretic analgesics, antidepressant, analgesic, cardiovascular, antispasmodic, antibacterial agent, histamines drug, and anticonvulsant. It also provides chemical products for intermediates and food additives. Zhej...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1998
• Employees: 663
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 001367

Financial Performance

In 2025, SHE:001367's revenue was 532.26 million, an increase of 12.88% compared to the previous year's 471.51 million. Earnings were 135.88 million, an increase of 10.87%.